title: Potassium channel blockers tetraethylammonium and 4-aminopyridine fail to prevent microglial activation induced by elevated potassium concentration.
abstract: The effect of potassium channel blocker tetraethylammonium and 4-aminopyridine was examined on the elevated K+ concentration-induced microglial activation on rat hippocampal slice preparations. Microglial cells were detected by immunohistochemisty with a monoclonal antibody (OX 42) raised against a type 3 complement receptor. During activation the morphology of the microglial cells changes and the staining intensity increases. The degree of microglial activation was determined by measuring the integrated optical density of the cells. Tetraethylammonium and 4-aminopyridine failed to reduce the elevated K+ concentration-induced microglial activation. Both potassium channel blockers, when applied on the hippocampal slices without K+, caused significantly increased microglial activation as compared to the control slices. In order to check whether the functional alteration of the neuronal population induced by 4-aminopyridine caused the activation of the microglial cells, Schaffer collaterals were cut to block spreading of epileptiform hyperactivity of the CA3 pyramidal cells to the CA1 region. No significant differences were found in microglial activation between the CA3 and CA1 regions, indicating that the effect of 4-aminopyridine on microglial cells is independent of the epileptiform activity caused by the drug.
authors.affiliation: Central Electron Microscopic Laboratory, Pécs University, Medical Faculty, Szigeti út 12, H-7643 Pécs, Hungary.
authors.forename: Hajnalka
authors.initials: H
authors.lastname: Abraham
authors.forename: A
authors.initials: A
authors.lastname: Losonczy
authors.forename: G
authors.initials: G
authors.lastname: Czéh
authors.forename: G Y
authors.initials: GY
authors.lastname: Lázár
mesh_terms: D015761:4-Aminopyridine / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000502:physiology; D004594:Electrophysiology / Q000379:methods; D005071:Evoked Potentials / Q000187:drug effects / Q000502:physiology; D066298:In Vitro Techniques; D008297:Male; D017628:Microglia / Q000187:drug effects / Q000502:physiology*; D011188:Potassium / Q000378:metabolism*; D026902:Potassium Channel Blockers / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D019789:Tetraethylammonium / Q000494:pharmacology*
chemical_list: D026902:Potassium Channel Blockers; D019789:Tetraethylammonium; D015761:4-Aminopyridine; D011188:Potassium